- Phare
 - Validé par KD/KO
 
Anticorps Polyclonal de lapin anti-TSC22D1
TSC22D1 Polyclonal Antibody for WB, IHC, IF/ICC, IP, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat et plus (1)
Applications
WB, IHC, IF/ICC, IP, ELISA
Conjugaison
Non conjugué
N° de cat : 10214-1-Ig
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | tissu cérébral humain, cellules A549, tissu cérébral de rat | 
| Résultats positifs en IP | tissu cérébral de rat | 
| Résultats positifs en IHC | tissu cérébral humain,  tissu testiculaire humain il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.  | 
| Résultats positifs en IF/ICC | cellules A549, | 
Dilution recommandée
| Application | Dilution | 
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 | 
| Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate | 
| Immunohistochimie (IHC) | IHC : 1:20-1:200 | 
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 | 
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| KD/KO | See 4 publications below | 
| WB | See 9 publications below | 
| IHC | See 2 publications below | 
| IF | See 2 publications below | 
| IP | See 2 publications below | 
Informations sur le produit
10214-1-Ig cible TSC22D1 dans les applications de WB, IHC, IF/ICC, IP, ELISA et montre une réactivité avec des échantillons Humain, rat
| Réactivité | Humain, rat | 
| Réactivité citée | Humain, souris | 
| Hôte / Isotype | Lapin / IgG | 
| Clonalité | Polyclonal | 
| Type | Anticorps | 
| Immunogène | TSC22D1 Protéine recombinante Ag0287 | 
| Nom complet | TSC22 domain family, member 1 | 
| Masse moléculaire calculée | 16 kDa | 
| Poids moléculaire observé | 16 kDa | 
| Numéro d’acquisition GenBank | BC000456 | 
| Symbole du gène | TSC22D1 | 
| Identification du gène (NCBI) | 8848 | 
| Conjugaison | Non conjugué | 
| Forme | Liquide | 
| Méthode de purification | Purification par protéine A | 
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol | 
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. | 
Informations générales
TSC22 domain family 1, transforming growth factor beta 1 induced transcript 4, (TSC22D1, synonyms: TSC22, TGFB1I4, MGC17597) is a member of a family of leucine zipper containing transcription factors with repressor activity and belongs to the large family of early response genes. TSC-22 regulates cell growth and differentiation, and cell death. Leucine zipper structure of TSC22 inhibits the anchorage independent growth of cancer cells. TSC-22 is also an important downstream component of peroxisome proliferator-activated receptor (PPAR) and TGF-beta signaling during intestinal epithelial cell differentiation. This antibody is a rabbit polyclonal antibody raised against an internal region of human TSC22D1.
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for TSC22D1 antibody 10214-1-Ig | Download protocol | 
| IHC protocol for TSC22D1 antibody 10214-1-Ig | Download protocol | 
| IF protocol for TSC22D1 antibody 10214-1-Ig | Download protocol | 
| IP protocol for TSC22D1 antibody 10214-1-Ig | Download protocol | 
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols | 
Publications
| Species | Application | Title | 
|---|---|---|
Cell Death Differ TSC-22D1 isoforms have opposing roles in mammary epithelial cell survival. | ||
Clin Cancer Res Transforming Growth Factor-{beta}-Stimulated Clone-22 Is an Androgen-Regulated Gene That Enhances Apoptosis in Prostate Cancer following Insulin-Like Growth Factor-I Receptor Inhibition.
  | ||
Int J Mol Sci Identification of Binding Proteins for TSC22D1 Family Proteins Using Mass Spectrometry. | ||
FEBS J Multiple TSC22D4 iso-/phospho-glycoforms display idiosyncratic subcellular localizations and interacting protein partners. | ||
Am J Physiol Heart Circ Physiol Transforming growth factor-beta1 regulation of C-type natriuretic peptide expression in human vascular smooth muscle cells: dependence on TSC22D1. | ||
Biochem Biophys Res Commun Low levels of TSC22 enhance tumorigenesis by inducing cell proliferation in colorectal cancer. | 










